ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,063Medicare Part D Prescriptions Filled, Including Refills

Rank: 167 out of 393

$195K Total Retail Price of All Prescriptions

Rank: 232 out of 393

242 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 242 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 242 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 4,789 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 297 272 1 1
HYDROCODONE-ACETAMINOPHEN 222 209 S3 2 5
LEVOTHYROXINE SODIUM 202 168 3 3
LISINOPRIL 200 194 4 2
OMEPRAZOLE 188 172 5 6
HYDROCHLOROTHIAZIDE 174 166 6 10
CITALOPRAM HBR 143 134 7 23
LOVASTATIN 107 107 8 14
METFORMIN HCL 101 100 9 7
TERAZOSIN HCL 99 99 10 38
WARFARIN SODIUM 96 96 11 17
ATENOLOL 95 95 12 13
RANITIDINE HCL 95 95 12 29
OXYCODONE HCL 95 93 S2 12 36
ALENDRONATE SODIUM 93 93 15 16
MORPHINE SULFATE ER 85 57 S2 16 48
GABAPENTIN 84 75 17 15
METOPROLOL TARTRATE 80 80 18 9
MELOXICAM 77 76 19 58
METOPROLOL SUCCINATE 75 75 20 22
POLYETHYLENE GLYCOL 3350 72 67 21 99
AMLODIPINE BESYLATE 71 68 22 4
FLUTICASONE PROPIONATE 68 47 23 27
FUROSEMIDE 65 65 24 8
POTASSIUM CHLORIDE 64 64 25 20
PRAVASTATIN SODIUM 63 61 26 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 47 27 24
LOSARTAN POTASSIUM 55 55 28 12
ZOLPIDEM TARTRATE 53 42 29 11
OXYBUTYNIN CHLORIDE ER 53 53 29 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.